SCHEMBL822184

SCHEMBL822184

C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2OC(=O)CO

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.85
KMT2A Q03164 7/20 0.85
CYP3A4 P08684 6/20 0.85
MEN1 O00255 6/20 0.85
TP53 P04637 4/20 0.85
ALOX15 P16050 3/20 0.85
MAPK1 P28482 3/20 0.85
LMNA P02545 7/20 0.80
SMN1; SMN2 Q16637 3/20 0.80
HIF1A Q16665 2/20 0.80
BRCA1 P38398 1/20 0.79
RECQL P46063 1/20 0.79
ESR1 P03372 5/20 0.79
PGR P06401 2/20 0.79
ADORA3 P0DMS8 2/20 0.79
AR P10275 2/20 0.79
PTGS1 P23219 2/20 0.79
PDE3A Q14432 2/20 0.79
POLB P06746 1/20 0.79
CHRM1 P11229 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19286812 1.00 MAPT (0.85) MAPTKMT2ACYP3A4MEN1TP53
SCHEMBL10653053 1.00 MAPT (0.85) MAPTKMT2ACYP3A4MEN1TP53
Estradiol Propionate SCHEMBL30384276 0.92 MAPT (1.00) MAPTKMT2ACYP3A4MEN1TP53
Estradiol Propionate SCHEMBL30165166 0.92 MAPT (1.00) MAPTKMT2ACYP3A4MEN1TP53
Estradiol Propionate SCHEMBL480992 0.92 MAPT (1.00) MAPTKMT2ACYP3A4MEN1TP53
Estradiol Propionate SCHEMBL26659949 0.92 MAPT (1.00) MAPTKMT2ACYP3A4MEN1TP53
SCHEMBL11273115 0.91 MAPT (0.83) MAPTKMT2ACYP3A4MEN1TP53
SCHEMBL19286799 0.91 MAPT (0.83) MAPTKMT2ACYP3A4MEN1TP53
SCHEMBL19286020 0.91 MAPT (0.71) MAPTKMT2ACYP3A4MEN1TP53
SCHEMBL19286815 0.91 MAPT (0.83) MAPTKMT2ACYP3A4MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 MAPT 826/4885KMT2A 3905/4885CYP3A4 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.